Cart is empty An international, multisite Phase III trial, co-led by a University of Cincinnati researcher, has found that a Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
An international, multisite Phase III trial, co-led by a University of Cincinnati researcher, has found that a Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
Leave A Comment